Related Experiment Video
Updated: Jun 4, 2026
Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
Published on: January 13, 2012
Carotid intervention 1: who should be treated?
1Sheffield Vascular Institute, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, United Kingdom.
Insights
Carotid artery disease significantly contributes to stroke. While medical therapy is standard, select patients may benefit from carotid endarterectomy or stenting, especially after recent symptoms, to reduce stroke risk.
Area of Science:
- Neurology
- Vascular Surgery
- Cardiology
Background:
- Stroke is a leading cause of death and disability worldwide.
- Atherosclerosis of the carotid arteries is a major contributor to ischemic stroke.
- Effective management of carotid artery disease is crucial for stroke prevention.
Purpose of the Study:
- To review the treatment strategies for carotid artery atheromatous disease.
- To evaluate the benefits of medical therapy, carotid endarterectomy, and carotid stenting in stroke prevention.
- To assess the risks and benefits in symptomatic versus asymptomatic patients and those undergoing concurrent procedures.
Main Methods:
- Review of current medical literature and clinical guidelines.
- Analysis of treatment outcomes for carotid endarterectomy and stenting.
- Evaluation of stroke risk stratification in patients with carotid artery disease.
Main Results:
- Medical therapy is recommended for all patients with carotid atheromatous disease.
- Symptomatic patients with high-grade carotid stenosis benefit most from early intervention (endarterectomy or stenting) with low complication rates.
- Asymptomatic patients have a lower stroke risk, necessitating highly selective treatment with minimal procedural morbidity.
- The practice of treating concurrent carotid disease during coronary artery bypass grafting lacks strong supporting data.
Conclusions:
- Optimal medical therapy is the cornerstone for managing carotid artery disease.
- Carotid revascularization (endarterectomy or stenting) offers significant stroke risk reduction in select symptomatic patients.
- Careful patient selection and low complication rates are paramount for interventions in both symptomatic and asymptomatic individuals.
- Further research is needed to clarify the benefits of treating carotid disease in patients undergoing coronary artery bypass grafting.
Abstract:
Stroke is a major cause of morbidity and mortality in the modern world. Carotid artery atheromatous disease is responsible for a significant number of these events. The effects of carotid artery disease may be prevented by appropriate treatment. All patients with known atheromatous disease should be treated with medical therapy. Despite this, some patients remain at high risk of stroke, which may be reduced by the selective use of additional therapies such as carotid endarterectomy or carotid stenting. Patients who have had recent neurological symptoms, attributable to their carotid disease, may benefit most from these additional treatments, particularly if the treatment is performed soon after the event. The operation needs to be performed with low complication rates. Some groups of patients who have been free of neurological symptoms may also benefit from these additional therapies, but these patients have a much lower inherent risk of stroke, and so the potential benefits are less. In such circumstances it is even more important that the operations are performed with minimal morbidity. Patients undergoing coronary artery bypass grafts, who also have carotid disease, are at elevated risk of stroke, and it is common practice to treat both conditions. There is no strong data to support this practice.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Aneurysm III: Interprofessional Care
01:30Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
01:22Cardiopulmonary Resuscitation II: ACLS Airway Management
01:26Angina IV: Management